Search Results


Your search for Michael Green, PhD matches 11 pages

Showing 1 - 11


Identifying Characteristics of Infused CAR T Cells Associated With Efficacy and Toxicity in Patients With Large B-Cell Lymphoma

Researchers have identified molecular and cellular characteristics of anti-CD19 chimeric antigen receptor (CAR) T-cell infusion products associated with how patients with large B-cell lymphoma respond to treatment and develop side effects. The research team also found that early changes in...

ASCO Welcomes 2020–2021 Board of Directors

ASCO is pleased to welcome the 2020–2021 Board of Directors and introduce the newly installed leaders who began their terms at the conclusion of the Annual Business Meeting on June 1, 2020. ASCO and the Board of Directors extend their sincere gratitude to the outgoing Board members whose terms...

ASCO, Conquer Cancer Congratulate 2019 Grant and Award Recipients

Conquer Cancer®, the ASCO Foundation, presented more than $7 million in grants and awards to exceptional oncology researchers at the 2019 ASCO Annual Meeting. ASCO and Conquer Cancer congratulate the recipients and offer their profound thanks to those who generously supported these awards. Visit...

hematologic malignancies

Leading Lymphoma Clinician, Researcher, and Mentor, Oliver ‘Ollie’ Press, MD, PhD, Dies at 65

In 1988, 38-year-old Rita Lawrence found herself in a desperate situation. The lymphoma she’d been battling had recurred after 2 years of remission. She’d endured multiple rounds of tough chemotherapy, but it couldn’t stave off the swiftly growing tumors. When she learned of a radioimmunotherapy...

ASCO Announces Candidates for 2017 Election

Twelve distinguished ASCO members have been selected by the Nominating Committee as candidates for open leadership positions within the Society, including the office of President-Elect, three seats on the Board of Directors, and two seats on the Nominating Committee. Biographical information and...

2016 ASCO Annual Meeting Planning Committees

The ASCO Annual Meeting highlights the latest research and treatment advances in oncology, with nearly 30,000 oncology professionals attending each year. ASCO wishes to acknowledge the volunteers on this year’s Cancer Education and Scientific Program Committees and thank them for their time and...

supportive care

Improving Treatment of Depression in Patients With Cancer: The SMaRT Oncology-2 Trial

Clinical depression is highly prevalent, associated with significant morbidity, often underrecognized, and inadequately treated in cancer patients.  Professor Michael Sharpe and Jane Walker, PhD, and their colleagues’ seminal work on enhancing treatment of depression in cancer patients using a...

issues in oncology

Considering Clonality in Precision Medicine

Precision cancer medicine entails treating patients based upon the molecular characteristics of their tumor. One could argue that we have been tailoring therapeutic regimens based upon tumor characteristics for years, whether it be treating patients based upon disease subtypes determined by...

National Academy of Medicine Elects New Members

The National Academy of Medicine (NAM), formerly the Institute of Medicine, announced the election of 70 regular members and 10 international members during its Annual Meeting October 19.  Election to the Academy is considered one of the highest honors in the fields of health and medicine and...

ASCO Announces Candidates for 2016 Election

Seventeen distinguished ASCO members have been selected by the ASCO Nominating Committee as candidates for open leadership positions within the Society. They include the office of President-Elect, four seats on the Society’s Board of Directors, and three seats on the ASCO Nominating Committee....

skin cancer
issues in oncology

Study Identifies Key Mechanism Involved in Promoting Melanoma Proliferation

Researchers have identified a microRNA, miR-146a, that accelerates in the presence of BRAF and NRAS genetic mutations—which occur in 70% of melanoma cases—by activating the Notch signaling pathway. The finding could provide a new drug development target for patients with melanoma. The...